WO2017189964A2 - Compositions for the treatment of disease - Google Patents
International application publshed with declaration under Article 17 (2) (a)
WO2014160160A2 - Antibody drug conjugates - Google Patents
US20140242671A1 - Cell Line for Production of Adeno-associated Virus - Google Patents
US9498543B2 - Antibody drug conjugates - Google Patents
WO2015095811A2 - Combination therapy with neoantigen vaccine - Google Patents
WO2021142221A1 - Compositions and methods for the treatment of neurodegenerative diseases - Google Patents
WO2017189964A2 - Compositions for the treatment of disease - Google Patents
US20170360960A1 - AAV Vectors Targeted to the Central Nervous System - Google Patents
Kyverna Therapeutics announces Phase 2 trial approval for KYV-101, a full human CD19 CAR T-Cell therapy for Myasthenia Gravis, by the FDA
WO2020223274A1 - SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS - Google Patents
US20140242671A1 - Cell Line for Production of Adeno-associated Virus - Google Patents
US20100204312A1 - Methods and compositions for treating cancer - Google Patents
WO2005013901A2 - Oligomeric compounds and compositions for use in modulation of small non-coding rnas - Google Patents
EP3385870A1 - Immunoglobulins with reduced aggregation - Google Patents
WO2017189964A2 - Compositions for the treatment of disease - Google Patents